The Quantellect read.As of Nov 19, 2026, 6 active firms cover Anheuser Busch Inbev NV ADR: 4 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $84.50 to $100.00, so the covering firms are broadly aligned. The average target of $90.27 sits 9% above the current $82.94. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.05 next quarter toward $4.88 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Buy
Strong Buy00%
Buy467%
Neutral233%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$90.27
+8.8% upside
Average target across 5 active firms as of Nov 19, 2026 vs $82.94 current
Highest Target$100.00
Average Target$90.27
Lowest Target$84.50
Detailed analyst forecasts for BUD
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 4 of 6 active firms rate BUD a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BUD EPS & revenue forecast
EPS · NEXT QUARTER
$1.05
Range $1.05 – $1.05 · 1 analysts · +8% YoY
Next period, 1 analysts expect Anheuser Busch Inbev NV ADR to earn $1.05 a share (range $1.05 – $1.05), versus $0.97 a year earlier. Full-year consensus is $4.42, growing to $4.88 the year after.
REVENUE · NEXT QUARTER
$16.1B
Range $16.1B – $16.1B · 1 analysts · +5% YoY
Revenue is expected to reach $16.1B (range $16.1B – $16.1B), +5.3% year-over-year. Full-year consensus is $64.8B, rising to $67.1B next year.
Top analysts covering Anheuser Busch Inbev NV ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BUD.
#1
Chris Carey
Wells Fargo · Rank #142
Buy
$88.00+6.1% to target
Overall win rate
46%
+ Follow
#2
ON
Olivier Nicolai
Goldman Sachs
Buy
$98.00+18.2% to target
Coverage
—
+ Follow
#3
AP
Andrea Pistacchi
Bank of America Securities
Buy
$94.00+13.3% to target
Coverage
—
+ Follow
#4
Robert Ottenstein
Evercore ISI Group
Buy
$105.00+26.6% to target
Coverage
—
+ Follow
#5
SS
Sarah Simon
Morgan Stanley
Buy
$84.50+1.9% to target
Coverage
—
+ Follow
BUD stock forecast FAQ
What is BUD's average 12-month price target?+
The 5 active firms with a live target average $90.27 for Anheuser Busch Inbev NV ADR over the next 12 months, ranging from a $100.00 high to a $84.50 low, as of Nov 19, 2026.
Is BUD stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 6 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BUD?+
The Street-high target is $100.00 (Evercore ISI Group), and the Street-low is $84.50 (Morgan Stanley). The average of all 5 active-firm targets is $90.27.
How many active Wall Street firms cover BUD?+
6 active firms have a recognized rating on Anheuser Busch Inbev NV ADR as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BUD?+
Among analysts who currently cover BUD, Chris Carey of Wells Fargo has the strongest overall Quantellect track record (Rank #142). Their current call is Buy with a $88.00 target.
What is Anheuser Busch Inbev NV ADR's projected EPS for next quarter?+
The consensus estimate is $1.05 per share (range $1.05 – $1.05) across 1 analysts. Full-year EPS is projected at $4.42, rising to $4.88 the following year.
How much revenue is Anheuser Busch Inbev NV ADR expected to report next quarter?+
Consensus revenue is $16.1B (range $16.1B – $16.1B). Full-year revenue is projected at $64.8B, growing to $67.1B next year.
Have analysts been upgrading or downgrading BUD lately?+
As of Nov 19, 2026, 4 of 6 active firms rate BUD a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BUD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.